10 February, 2021
A new molecular test detects genetic abnormalities in tumours and improves customised cancer diagnosis and treatment
At the Grupo Hospital Clínic, we have a new option for diagnosis of advanced cancer. It is a new test using Next Generation Sequencing (NGS) technology which, by analysing the tumour’s DNA and RNA, detects multiple genetic abnormalities in 52 of your genes. This new cancer diagnostic test allows your treatment to be further customised. In addition, it improves current tests for the diagnosis of lung, colon and rectal cancer and melanoma.
9 January, 2019
New barnaclínic+ genetic study to detect risk of cancer, early diagnosis and prevention
For the past few days, barnaclínic+ has been offering the possibility of carrying out a genetic study to detect cancer risk. It is an early detection test for the risk of developing some types of cancer and, above all, what is known as hereditary cancer.
Read more…
